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Abstract
Background: Burma records the highest number of malaria deaths in southeast Asia and may
represent a reservoir of infection for its neighbors, but the burden of disease and magnitude of
transmission among border populations of Burma remains unknown.
Methods: Plasmodium falciparum (Pf) parasitemia was detected using a HRP-II antigen based rapid
test (Paracheck-Pf®). Pf prevalence was estimated from screenings conducted in 49 villages
participating in a malaria control program, and four retrospective mortality cluster surveys
encompassing a sampling frame of more than 220,000. Crude odds ratios were calculated to
evaluate Pf prevalence by age, sex, and dry vs. rainy season.
Results: 9,796 rapid tests were performed among 28,410 villagers in malaria program areas
through four years (2003: 8.4%, 95% CI: 8.3 – 8.6; 2004: 7.1%, 95% CI: 6.9 – 7.3; 2005:10.5%, 95%
CI: 9.3 – 11.8 and 2006: 9.3%, 95% CI: 8.2 – 10.6). Children under 5 (OR = 1.99; 95% CI: 1.93 –
2.06) and those 5 to 14 years (OR = 2.24, 95% CI: 2.18 – 2.29) were more likely to be positive than
adults. Prevalence was slightly higher among females (OR = 1.04, 95% CI: 1.02 – 1.06) and in the
rainy season (OR = 1.48, 95% CI: 1.16 – 1.88). Among 5,538 rapid tests conducted in four cluster
surveys, 10.2% were positive (range 6.3%, 95% CI: 3.9 – 8.8; to 12.4%, 95% CI: 9.4 – 15.4).
Conclusion: Prevalence of plasmodium falciparum in conflict areas of eastern Burma is higher than
rates reported among populations in neighboring Thailand, particularly among children. This
population serves as a large reservoir of infection that contributes to a high disease burden within
Burma and likely constitutes a source of infection for neighboring regions.
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There exists an acute imperative to improve infectious dis-
ease surveillance in the border regions of Burma. The
combination of multi-drug resistant plasmodium falci-
parum (Pf), [1,2] ubiquitous fake antimalarials, [3,4] and
under funding of malaria control within a health system
ranked 190th out of 191 countries by the WHO in 2000,
results in more malaria deaths (1,707) in Burma than any
other country in southeast Asia (52.6% of WHO South
East Asia Region) [5]. Official statistics are likely to grossly
underestimate the number of malaria cases and deaths,
especially in remote areas where ongoing civil conflict
likely increases malaria risk [6,7]. The most recent WHO
country report for Burma provides a striking example of
underreporting of malaria morbidity in Karen (Kayin)
State. In the same year (2003) that WHO recorded 2,016
malaria cases for the entire state, the Karen Department of
Health and Welfare (KDHW) and mobile medics of the
Backpack Health Worker Team (BPHWT) treated 27,000
cases in a population of fewer than 300,000 internally dis-
placed persons in Karen State. Furthermore, the Mae Tao
Clinic, located across the border from Karen State in Thai-
land treated over 5,000 confirmed cases of malaria from
Burma [8].
Poor malaria control in Burma likely contributes to
malaria transmission in neighbouring countries [9-12].
The Thai province of Tak, adjacent to Karen state, has the
highest numbers of cases of malaria in the country, and
recorded more than twice as many cases (9,339) among
Burmese migrants as among Thai locals (4,420) in 2001
[10]. Malaria prevalence in Burmese migrants in Thailand
(4.4%) is up to 20 times that of Thai locals (0.2%);[4] and
proximity to the Burma border is positively associated
with malaria parasitemia [10,11]. Burma may represent a
reservoir of infection for its neighbours, but few data exist
on the magnitude of transmission among border popula-
tions of Burma.
There are two published estimates of malaria prevalence
in eastern Burma. Overall Pf prevalence was 15.8% among
a convenience sample of symptomatic Burmese villagers
(n = 703) seeking care in Thailand in 2001 [11]. A cluster
mortality survey conducted in a conflict zone of eastern
Burma in 2004 estimated a 12.4% (216/1739) prevalence
among asymptomatic villagers [13].
The goals of the present analysis are: 1) to describe the
prevalence of Pf in an area of active conflict in eastern
Burma; 2) to explore the epidemiology of Pf parasitemia
by age, sex, and season; and 3) to compare prevalence esti-
mates from observational malaria program data and retro-
spective mortality cluster surveys.
Methods
Population
In late 2004 there were an estimated 526,000 internally
displaced persons (IDPs) in eastern Burma, and at least
240 villages had been destroyed, forcibly displaced or
abandoned in the prior two years [14]. Conservative esti-
mates of ongoing displacement suggest that an additional
167,000 people and 300 villages were forced to move in
the two years subsequent to the 2004 report [15].
Data in this study were collected from the so-called "black
zones" in eastern Burma where health services are unavail-
able from either the military regime or international
organizations. Services for a population of approximately
250,000 are provided primarily by ethnic health organiza-
tions of the Karen Department of Health and Welfare
(KDHW) and the Backpack Health Worker Team
(BPHWT), whose broad geographic target area extends
from Mergui-Tavoy in the South to Karenni (Kayah) area
in the North, and from the Thai-Burma border to slightly
west of the Sittang River in eastern Pegu (Bago) Division.
(Figure 1) For the purposes of service delivery and health
information the two populations are mutually exclusive,
in that BPHWT was designed to serve populations unable
to access ethnic health clinics due to distance and/or secu-
rity.
KDHW administers 33 clinics to provide primary health
care to approximately 95,000 persons. These semi-perma-
nent clinics are located in relatively stable areas of Karen
State, but are designed for rapid relocation in the case of
threats to population security. Eleven clinics have been
forced to relocate since 1998, five from October 2006 to
April 2007. BPHWT is comprised of over 300 health work-
ers divided into 76 teams designed to reach an additional
152,000 persons in less stable areas. Since inception of the
program in 1998, seven BPHWT health workers have died
while carrying out their health care provision responsibil-
ities.
This report summarizes and compares Pf prevalence esti-
mates derived from two types of data sources: cross-sec-
tional screenings conducted as part of the KDHW malaria
program from 2003 to 2006, and retrospective cluster sur-
veys designed to estimate infant mortality rates in the
entire BPWHT and KDHW populations in 2004 and 2006.
Both the malaria program and the cluster surveys identi-
fied Pf parasitemia with a rapid diagnostic device (RDT;
Paracheck-Pf® Orchid Biomedical Systems, Goa, India).
Integrated Malaria Control Program
In 2003 the KDHW initiated an integrated malaria control
program in four villages with a total population of 1,819.
By 2006 the program reached 28,498 persons in 49 vil-
lages (village population size range: 162 – 1,824). ThisPage 2 of 10
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95,000. The pilot program included distribution of long-
lasting insecticide treated nets (LLITNs), malaria educa-
tion messages, and early detection with the Paracheck-Pf®
device and therapy with mefloquine-artesunate for three
days (MAS3). Baseline screenings were conducted prior to
initiation of malaria control activities, permitting the esti-
mation of malaria prevalence among new villages in each
year.
The decision to actively screen a population living in an
area of unstable transmission was based on the dramatic
success of a similar strategy in Vietnam [16,17] and later
in Brazil [18,19] and Cambodia [20]; and on growing,
albeit inconsistent, evidence for asymptomatic infections
in areas of unstable transmission [21-23] including
Burma [24,25].
Screening was universal in the first phase of the program
(2003–2004). However, in order to reduce costs, limited
screening was conducted in 10 of 14 new villages in 2005,
and all new villages in 2006 (N = 27). Limited screenings
included a systematic sample of 100 heads of household.
Females were preferentially sampled during limited
screenings in order to minimize the workload of health
workers operating in a conflict zone, and to maximize the
likelihood of identifying parasitemia in women of repro-
ductive age. Villages with fewer than 100 households in
2006 (N = 11) screened only one person per household.
All participants with a positive test result in either the
malaria program or the cluster surveys (described below)
received MAS3, as recommended by regional guidelines
[26].
Parasitemia prevalence is reported as the proportion of
the screened population with a positive Paracheck-Pf® test
result [(number Pf positive)/(total number screened)].
Estimates in 2005 and 2006 were weight-adjusted by vil-
lage population size. Confidence intervals for prevalence
estimates were calculated for finite populations to account
for near-complete sampling by multiplying the standard
error by the square root of (1 - p), where p is the propor-
tion of the population that is sampled [CI = +/- 1.96 *
SE ].
Prevalence estimates from the eleven villages conducting
universal screening were stratified by sex and age (<5, 5–
14, and 15+ years), and crude odds ratios and their 95%
confidence intervals were calculated. The rainy season was
defined as the 5 months from June through October to
account for parasite development in the mosquito follow-
ing the onset of the rainy season between May and early
October.
Cluster Survey Design
This report included results from four retrospective mor-
tality cluster surveys conducted in two different years in
the two mutually exclusive target populations of the
BPHWT and KDHW. Between October and December in
2004 and 2006, BPHWT and KDHW health workers con-
ducted retrospective household surveys of vital events and
human rights violations occurring in the 12 months prior
to the interview. The design, implementation, and opera-
tional method of the surveys have been described previ-
ously [13,27]. Briefly, in 2004 and 2006 annual village
census information was used to construct a sampling
frame for the target population (~130,000) and spanning
eight administrative areas (Figure 1). In 2004, one hun-
dred village-based clusters (200 in 2006) were selected
( )1− p
Target area of the KDWH and BPHWTFigure 1
Target area of the KDHW and BPHWT. BPHWT: Back-
pack   Health Worker Team; KDHW: Karen Department of 
Health & Welfare.Page 3 of 10
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households within each cluster were selected using sys-
tematic interval sampling. Design and implementation of
surveys in KDHW areas differed only in the size of the
sampling frame (~95,000).
At each household, surveyors explained the objectives and
obtained verbal consent for participation. The survey
included a listing of all household members by age and
sex, and documented falciparum malaria parasitemia for
the respondent using the Paracheck-Pf® device.
Sample Size and Analysis of Cluster Surveys
The proposed sample size for each survey was based on a
balance of operational feasibility and resource constraints
and the goal of continued monitoring of the infant mor-
tality rate. Population proportions were estimated for sev-
eral morbidity outcomes, including the proportion of
respondents testing positive for Plasmodium falciparum. All
confidence intervals were adjusted for the cluster sam-
pling. The sample size allows for the estimation of para-
sitemia prevalence to within 2%, assuming baseline
prevalence = 10%, overall survey completion rate = 85%,
and design effect = 2.0.
Ethical Approval
Data were collected as part of routine program monitor-
ing and evaluation. Data forms were brought from the
field to Mae Sot, Thailand where they were entered into a
computerized database (Microsoft ACCESS) and were
cleaned using range and internal consistency checks. The
survey protocol and malaria program data collection
instruments were approved by local leaders of the Burma
Medical Association. The Johns Hopkins University Com-
mittee on Human Research approved the secondary anal-
ysis of the cluster survey data. The authors of this paper
were responsible for the secondary analysis, conducted
with Stata 8.2 (Stata Corp., College Station, TX, USA).
Results
Malaria Program Screenings
Between 2003 and 2006 a total of 9,796 RDTs were per-
formed among 28,410 villagers participating in 11 univer-
sal (n = 5,872) and 36 limited (n = 3,924) baseline
screenings. Each baseline screening was completed in
approximately 3 (median) days, (range 1–7). Overall par-
ticipation in universal screenings was 98.1% (village
range 87–100%) of the expected population. Overall 800
RDTs were positive for Pf, representing a weighted-mean
prevalence of 9.5%, 95% CI: 8.7 – 10.2.
Overall prevalence estimates derived from baseline uni-
versal and limited screenings in each year from 2003 to
2006 are presented in Figure 2. Prevalence in malaria pro-
gram areas was similar over four years (2003: 8.4%, 95%
CI: 8.3 – 8.6; 2004: 7.1%, 95% CI: 6.9 – 7.3; 2005:10.5%,
95% CI: 9.3 – 11.8 and 2006: 9.3%, 95% CI: 8.2 – 10.6).
There was substantial inter-village variation of Pf preva-
lence among villages (range 0% – 28.6%). In 2005, the
only year that included both universal and limited screen-
ings, combined prevalence in ten villages conducting lim-
ited screening (12.5%, 95% CI: 10.6 – 14.4%) was higher
than in four universally screened villages (6.4%, 95% CI:
6.3 – 6.5).
Age, Sex & Season
Universal screenings in 11 malaria program villages from
2003 to 2005 permitted comparison of Pf prevalence by
age and sex (Table 1). Children under 5 years old (preva-
lence 9.6%) and children 5 to 14 years old (10.8%) had
approximately twice the odds of testing positive (respec-
Table 1: Plasmodium falciparum prevalence from baseline universal screening in KDHW malaria control program villages (2003–2005), 
by age and sex
Crude OR (Finite Population 95% CI)
N Pf (+) Pf (%) Sex* Age**
Age <5
Male 499 48 9.6% 0.99 (0.93 – 1.06) 1.99 (1.93 – 2.06)
Female 486 47 9.7%
Age 5–14
Male 710 75 10.6% 0.97 (0.93 – 1.01) 2.24 (2.18 – 2.29)
Female 721 79 11.0%
Age 15+
Male 1,800 99 5.5% 1.18 (1.14 – 1.21) (--)
Female 1,655 78 4.7%
All Ages
Male 3,009 222 7.4% 1.04 (1.02 – 1.06) (--)
Female 2,862 204 7.1%
* Reference category is female within age category
**Reference category is individuals 15 years and abovePage 4 of 10
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2.29) as adults 15 years or older (prevalence 5.1%). Prev-
alence was slightly higher among males (7.4%) than
females (7.1%), though the difference overall was small
(0.3%; OR 1.04, 95% CI: 1.02 – 1.06) and was attributa-
ble to a difference between male (5.5%) and female
(4.7%) adults (OR 1.18, 95% CI: 1.14 – 1.21).
Limited screening with 1,054 RDTs among 5,449 pre-
dominantly female (80 – 98%) heads of household in 10
villages in 2005, and 2,870 RDTs among 17,602 in 27 vil-
lages in 2006 facilitated the evaluation of the association
of Pf prevalence with rainy and dry season. (Table 2) Prev-
alence was higher in the rainy season than the dry season
in both 2005 (weighted prevalence 15.2% vs. 11.6%) and
2006 (12.4% vs. 8.3%; combined 2005–2006 OR 1.48,
95% CI: 1.16 – 1.88).
Cluster Survey Results
To estimate Pf parasitemia prevalence in the entire target
population among female heads of household, in 2004
and 2006 the mobile workers of the BPHWT conducted a
total of 1,834 and 1,614 household surveys, representing
92% and 90% of the respective target sample populations.
A slightly lower proportion (83%) was returned from
KDHW areas in 2004. Characteristics of the survey sam-
ples are summarized in Table 3. A total of 5,538 rapid tests
for parasitemia were conducted in four cluster surveys,
representing 80% of respondents overall. Overall 10.2%
(range 6.3% – 12.4%) were positive (Table 3). Prevalence
point estimates were lower in both BPHWT and KDHW
areas in 2006 than in 2004, though the difference reached
statistical significance only for BPHWT surveys. The
KDHW 2006 sampling frame included seven clusters in
malaria control program areas (n = 180) where the preva-
lence (1.7%) was lower than in non-MCP clusters (n =
1,267, prevalence 9.1%).
Discussion
The prevalence of plasmodium falciparum in conflict areas
of eastern Burma prior to malaria interventions has
remained high (at least 6.3% – 12.5%) over the four year
period 2003–2006. Estimates are derived from over
15,000 rapid tests performed in a combined target popu-
lation of over 225,000 persons and represent one of the
largest samples reported from southeast Asia. The range of
village prevalence (0 – 28.6%) is consistent with smaller
reports from other areas of Burma (range 10–40%)
[11,28-30]. The overall prevalence estimate presented
here is higher than the prevalence of 3.9% (range 2–7%)
documented in 2006 in four Burmese villages along the
Thai border with ongoing malaria control efforts [31].
Prevalence in eastern Burma is also higher than that
recorded among Thai villagers (prevalence <2%) and for-
eign nationals (<3.5%) in Thailand, [11] confirming the
presence of a malaria reservoir in eastern Burma that likely
contributes to transmission in border regions of Thailand.
Age
The higher Pf prevalence we observed in children com-
pared to adults is consistent with population surveys in
ecologically similar areas of Laos, [32] Cambodia [20,23]
and Burma. For example, Tun-lin et al. documented
higher prevalence in children under ten (30%–50%) than
in adults (10–27%) during four successive screenings (n =
146 – 168) in a single village in central Burma in 1992 –
1993 [28]. However, an HRP-II antigen assay might over-
estimate Pf prevalence in children relative to adults, as
acquired immunity in adults might lead to lower para-
sitemia levels and may decrease the sensitivity of the anti-
gen assay.
Sex
We did not observe large differences in Pf prevalence
between males and females in either children or adults.
These results differ from the observation of a four-fold
higher Pf prevalence among male (9%) vs. female (2%)
adults in four Burmese villages immediately across the
Thai border with access to early detection and treatment
(EDT), [31] as well as from other studies southeast Asia
that have documented increased exposure of male adults
to infected mosquitoes due to forest related activities
[23,28,33,34]. The discrepant observations may reflect a
difference in forest-related behaviors or an influence of
the location and/or stability of villages; but may also
Estimates of Plasmodium falciparum prevalence from   malaria progr m screenings and retrospective cluster surveys 2003 –2006, by easo .Figu e 2
Estimates of Plasmodium falciparum prevalence from malaria 
program screenings and retrospective cluster surveys 2003 – 
2006, by season. BPHWT: Backpack Health Worker Team; 
KDHW: Karen Department of Health & Welfare. Limited 
program screenings targeted female heads of household. 
Rainy season defined as the months from June – October.Page 5 of 10
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interventions prior to our surveys. The higher Pf preva-
lence in males noted in other studies may reflect the rela-
tive impact of malaria control programs in adult men and
women, and may not reflect the sex distribution of asymp-
tomatic Pf among adults prior to program implementa-
tion.
Season
Overall prevalence was higher during the rainy season in
both 2005 and 2006. This seasonal variability, however,
appears to be less than that observed in Pf incidence
among Burmese migrants [10] and refugees [35] in Thai-
land. These data are similar to those from bi-annual
screenings conducted in four Burmese villages in 2006 (Pf
prevalence 3.9% in both the rainy and dry seasons) in the
setting of ongoing malaria control [31].
Malaria Program Screenings vs. Cluster Surveys
In 2004, cluster surveys produced higher estimates of Pf
prevalence (12.4% and 11.8%) than program areas
(7.1%). There are several possible reasons for this discrep-
ancy. In 2004, malaria program screenings included
nearly the entire population, whereas cluster surveys
screened only heads of households, who may be more
likely to engage in behaviours with elevated malaria risk,
such as forest-related activities. While we did not directly
measure malaria risk behaviours, in universally screened
malaria program areas we observed that adults were at sig-
nificantly lower risk than children. Alternatively, the
Table 2: Plasmodium falciparum prevalence estimated from limited screening* in KDHW malaria program villages (2005–2006), by 
season
2005 2006
Season Dry Rainy** Dry Rainy**
# Villages 7 3 20 7
Population 4,004 1,445 11,923 4,306 Crude OR (Finite Population 95% CI)
Rapid Tests
Performed
735 319 2,246 624
Proportion
Female
0.90 0.81 0.98 0.84 Rainy Season Year (2006/2005)
Prevalence 11.6% 15.2% 8.3% 12.4%
95% CI*** (9.4 – 13.8) (11.5 – 18.9) (7.3 – 9.4) (9.3 – 15.0) 1.48 (1.16 – 1.88) 0.72 (0.58 – 0.89)
*Limited program screenings targeted female heads of household
**Rainy Season = June – October
***Confidence intervals adjusted for sampling without replacement within a finite population
Table 3: Cluster Survey Target Population, Response Rate and Pf Prevalence
2004 2006
Sample Characteristic BPHWT* KDHW BPHWT KDHW**
Target Population 129,000 96,888 134,732 89,092
Number of Clusters 
Sampled
100 100 180 100
Number of Clusters 
Successfully Reached
92 84 164 88
Total Households Sampled 1,834 1,657 1,614 1,835
Response Rate 92% 83% 90% 92%
Number of Malaria Rapid 
Tests Performed
1,739 1,588 882 1,329
Proportion of Respondents 
Tested
95% 96% 55% 72%
Proportion Female 62% 92% 84% 99%
Plasmodium falciparum 
Prevalence
12.4% 11.8% 6.3% 8.2%
Cluster Adjusted 95% 
Confidence Interval
(9.4 – 15.4) (9.5 – 14.2) (3.9 – 8.8) (5.1 – 11.3)
BPHWT: Backpack Health Worker Team; KDHW: Karen Department of Health & Welfare
* BPHWT 2004 survey results reported previously in Mullany, Richards, Lee et al. (2007). See reference 13.
** KDHW 2006 sampling frame includes seven malaria control program areas (n = 180) with Pf prevalence of 1.7%. Prevalence in non-MCP clusters 
(n = 1267) was 9.1%.Page 6 of 10
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may reflect differences in village location, stability and/or
exposure to human rights violations. Studies have docu-
mented an increased risk of malaria among migrants
[34,36] and in the setting of complex emergencies [7,37].
Results reported elsewhere [13] from the 2004 survey in
BPHWT areas suggest that malaria prevalence may be
associated at the household level with forced displace-
ment, forced labour, and destruction of food supply, and
that exposure to multiple human rights violations
increases risk.
Location and stability may also have contributed to the
higher prevalence observed in 2005 among malaria pro-
gram villages conducting limited screening among heads
of household (population weighted prevalence 12.5%,
95% CI: 7.5 – 17.5) compared to universally screened vil-
lages (6.4%, 95% CI: 6.3 – 6.5), which tended to be
located among more stable populations. The villages with
the highest prevalence in both 2004 (Mae Ngaw, 17%)
and 2006 (Ei Tu Hta, 29%) were the least stable villages in
those years. Mae Ngaw subsequently was destroyed by the
military in early 2005 and Ei Tu Hta was a newly formed
encampment for persons internally displaced in early
2006 by an escalation of violence near the new Burmese
capital of Pyinmana (Naypyidaw).
Limitations
Sequential estimates of Pf prevalence in new malaria pro-
gram areas perforce relied on screening different villages
in each term, which likely resulted in substantial bias by
area and other unmeasured factors. An alternative
approach to include longitudinal measurements in inter-
vention-naïve villages would have minimized this bias,
but was not possible in this setting, as implementing part-
ners felt it would be unethical to withhold effective inter-
ventions from vulnerable populations. Furthermore, the
increasingly large number of areas included in screenings,
as well as triangulation with estimates from cluster sample
surveys, enhances the external validity of our findings to
other villages in "black zones" of eastern Burma.
We did not conduct universal screenings in all villages.
However, the number of RDTs from universal screenings
performed from 2003–2005 (n = 5,871) permitted evalu-
ation of associations with age and sex; and limited screen-
ing resulted in significant cost savings to facilitate
program expansion to additional villages. In universally
screened villages, the Pf prevalence overall was higher
(7.2%) than the estimate among adult women (4.4%)
and this relationship was consistent for each year in which
universal screening was conducted. This suggests that the
population prevalences in cluster surveys and in program
areas conducting limited screening, where adult women
were over-sampled, likely underestimate the true popula-
tion-based burden of parasitemia.
The use of a rapid diagnostic test may have limited our
ability to detect low level parasitemia [38-40]. However,
Paracheck-Pf® has demonstrated impressive sensitivity
and specificity under field conditions during asympto-
matic screening of children in India (sensitivity/specificity
94.4 & 89.0%, respectively), [41] and in Tanzanian vil-
lages with either high (40.1%), low (4.3%), or very low
(1.9%) P. Falciparum prevalence (sensitivity 83.6, 100%,
n/a; specificity 94.1%, 99.5%, 98.4% respectively)
[42,43]. Furthermore, the alternative diagnostic strategy
in areas where PCR is unavailable – field microscopy – has
shown poor sensitivity (~10%) for asymptomatic P. Falci-
parum parasitemia [22] when compared to expert micros-
copy in western Thailand, [44] suggesting Paracheck-Pf®
may be at least as accurate as field microscopy in this set-
ting. The accuracy of RDTs may be compromised by high-
temperatures or prolonged storage under field conditions,
[42] but storage in thatched huts likely minimized
extreme temperatures in our case. Low RDT sensitivity
would have resulted in an underestimation of parasitemia
prevalence. It is unlikely that false positives (due to low
specificity) accounted for a high proportion of prevalent
cases during baseline screenings, given the consistently
low prevalence (<2%) recorded during follow-up in most
malaria program areas during program implementation
[45].
Although most participants were asymptomatic at the
time of testing, those with a positive RDT were treated
immediately; therefore we are unable to distinguish
between pre-clinical and chronic asymptomatic infection.
Other studies from Burma, [24,25] Cambodia, [23] Tan-
zania [43] and South America [18,21,46] suggest that pro-
tective immunity (premunition) is not uncommon in the
setting of unstable transmission; and that asymptomatic
infection is infectious to mosquitoes despite a low asexual
parasite burden [46-48]. The relatively high prevalence of
predominantly asymptomatic parasitemia in this report
adds to the growing body of evidence supporting the pres-
ence of asymptomatic infection in areas of unstable
malaria transmission. Additional studies are needed to
estimate the prevalence of asymptomatic carriers in east-
ern Burma and to evaluate the role of active case detection
in reducing malaria transmission.
We did not estimate the prevalence of plasmodium vivax
(Pv), though Pv appears to account for no more than 20%
of malaria infections in Burma [6] and almost certainly
represents an even smaller fraction of malaria related
deaths. We did not directly measure rainfall, [49] migra-
tion, [36] forest-related activity, proximity to water [50] orPage 7 of 10
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founded the associations we observed.
Rapid testing with accurate RDTs is easily integrated into
malaria control programs and cluster surveys designed to
estimate other health indicators, and provides a simple
and cost-effective means to estimate cross-sectional prev-
alence of parasitemia. Triangulation of data from different
sources enhances the validity of parameter estimates.
Additional studies are necessary to quantify malaria risk
in eastern Burma, including the role of age and sex, eleva-
tion, season, migration, forest-related activities and civil
conflict. Increasing capacity for EDT offers an opportunity
to directly monitor the more clinically relevant incidence
of symptomatic Pf, and to improve our understanding of
the relationship between Pf incidence and prevalence in
this setting. In a region with highly drug resistant Pf [2,52]
and ubiquitous fake antimalarials [3,53] efforts to track
treatment failures and to monitor in vitro drug susceptibil-
ity and antimalarial quality should be expanded in unsta-
ble areas in eastern Burma.
Conclusion
Prevalence of plasmodium falciparum in a large population
in conflict areas of eastern Burma remains high relative to
the prevalence reported among populations in neighbor-
ing Thailand, particularly among children. There is an
immediate need to expand malaria interventions to
reduce morbidity and mortality in conflict areas in eastern
Burma and to reduce the reservoir of infection that com-
promises regional disease control efforts.
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